Is a Retroaortic Vein a Risk Factor in Laparoscopic Living Donor Nephrectomy?


Journal

Urologia internationalis
ISSN: 1423-0399
Titre abrégé: Urol Int
Pays: Switzerland
ID NLM: 0417373

Informations de publication

Date de publication:
2020
Historique:
received: 18 01 2020
accepted: 27 02 2020
pubmed: 18 5 2020
medline: 23 4 2021
entrez: 18 5 2020
Statut: ppublish

Résumé

In living donor transplantation choosing the right donor and donor side for laparoscopic donor nephrectomy is a challenging task in clinical practice. Knowledge about anomalies in renal blood supply are crucial to evaluate the feasibility of the operative procedure. Few data so far exist whether the existence of a retroaortic left renal vein has an impact on living kidney transplantation outcome for donor and recipient. We retrospectively analyzed 221 patients who underwent laparoscopic living donor nephrectomy between 2011 and 2017 for existence of a retroaortic left renal vein. Clinical characteristics and operative outcomes for donors and recipients were analyzed. 221 patients underwent donor nephrectomy between 2011 and 2017; 11 patients (4.98%) showed the feature of a retroaortic left renal vein, and in 8 patients (72.7%) out of those 11 the left kidney was chosen for transplantation. Mean preoperative serum creatinine was 0.77 (0.49-0.98) mg/dL and 1.28 (0.97-1.64) mg/dL at discharge. In recipients mean serum creatinine preoperatively, after 1 week, 1 month,1 year, 2 and 3 years of follow-up was 10.36 (6.09-20.77) mg/dL, 1.71 (0.67-2.72), 1.33 (0.70-1.89), 1.31 (0.95-2.13), 1.31 (0.98-2.13) and 1.33 (1.03-1.84), respectively. Neither donors nor recipients suffered from any operative complications. Laparoscopic living donor nephrectomy of a left kidney with retroaortic renal vein is safe for the donor, without limitation in the outcome for the recipient.

Identifiants

pubmed: 32417839
pii: 000507642
doi: 10.1159/000507642
pmc: PMC7592925
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

641-645

Informations de copyright

© 2020 The Author(s) Published by S. Karger AG, Basel.

Références

Int Braz J Urol. 2017 Jul-Aug;43(4):671-678
pubmed: 28379667
Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1678-86
pubmed: 26268509
Langenbecks Arch Surg. 2014 Jun;399(5):543-51
pubmed: 24770877
Surg Radiol Anat. 2015 Aug;37(6):667-75
pubmed: 25567101
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Chirurgia (Bucur). 2017 Mar-Apr;112(2):124-129
pubmed: 28463678
Urol Int. 2016;97(4):450-456
pubmed: 27577572
Transplantation. 2001 Mar 15;71(5):660-4
pubmed: 11292298
World J Urol. 2020 Apr;38(4):919-927
pubmed: 31129713
AJR Am J Roentgenol. 1988 Dec;151(6):1149-51
pubmed: 3055890
J Endourol. 2009 Mar;23(3):451-5
pubmed: 19245297
Radiographics. 2010 Nov;30(7):1875-90
pubmed: 21057125
Folia Med (Plovdiv). 2014 Jan-Mar;56(1):38-42
pubmed: 24812921
Transplant Proc. 2011 May;43(4):1230-2
pubmed: 21620097
BJU Int. 2013 Jan;111(1):95-100
pubmed: 22757693
J Urol. 2004 Jan;171(1):44-6
pubmed: 14665840
Urol Int. 1975;30(5):332-40
pubmed: 1189130

Auteurs

Josef Mang (J)

Department of Urology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Linda Hennig (L)

Department of Urology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Nadine Biernath (N)

Department of Urology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Lutz Liefeldt (L)

Department of Nephrology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Anna Bichmann (A)

Department of Anesthesiology and Operative Intensive Care Medicine, Campus Charité Mitte, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Bernhard Ralla (B)

Department of Urology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Andreas Maxeiner (A)

Department of Urology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Robert Peters (R)

Department of Urology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Hannes Cash (H)

Department of Urology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Klemens Budde (K)

Department of Nephrology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Frank Friedersdorff (F)

Department of Urology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany, Frank.Friedersdorff@charite.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH